Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
Research in the economic sciences lies at the heart of addressing global societal challenges and achieving progress towards the UN Sustainable Development Goals. The Nature Research journals welcome the submission of research across the spectrum of economic sciences and allied disciplines. This Collection highlights economics research from a range of Nature Research journals that feature economics as a priority area in their scope.
Regardless of country and discipline, publications are an expectation – if not a requirement – to obtain a PhD. In this Focus issue, PhD students, academics and external stakeholders describe how this focus on publications leads to both, detrimental consequences but also benefits, for individuals and the scientific community. The 28 varied contributions include clear calls for future improvements of the system of support, training, and assessment of PhD students. The discussion is amplified with more contributions on the Behavioural and Social Science community forum (https://socialsciences.nature.com/channels/2140-is-it-publish-or-perish).
This focus presents original research evaluating the replicability of twenty-one social science experiments published in Nature and Science between 2010 and 2015 and the responses from eight authors of the original studies whose effects did not replicate (according to the criteria proposed by the replicating authors).
Cooperation lies at the heart of human lives and society. Understanding how and when it succeeds and fails is key to solving global challenges. In this Focus issue, we pull together papers from across the journal's broad disciplinary scope to understand the state of knowledge on cooperation and highlight future research directions.
As of January 25, 2018, the NIH, the biggest funder of biomedical research in the world, is implementing policy changes which will affect the majority of US laboratories working with human subjects.
We think it is vital for all parties, external stakeholders and the public to engage in an informed, productive debate about these developments to identify issues and opportunities. In this special collection of commissioned opinion pieces, representatives of international funding agencies and science regulators, non-profit organizations and think tanks, and leading basic and clinical researchers in the US and Europe contribute novel, thought-provoking arguments. In an accompanying Q&A, Michael Lauer of the NIH addresses questions regarding the implementation and gives advice on future grant applications.